Objective:

In March 2020, the disease caused by the coronavirus SARS-CoV-2 (COVID-19) was declared a pandemic. It was initially estimated that 5% of the population affected by COVID-19 required admission to intensive care units with invasive mechanical ventilation support, and may develop sequelae from hospitalization. The home rehabilitation team proposes the challenge of carrying out a series of evaluations in order to be able to assess rehabilitation in the home environment.

Method:

Uncontrolled clinical trial of patients from the home hospitalization unit who have suffered from COVID-19 with the use of IMV, between June 2020 and June 2021. 193 patients were admitted, who underwent surgery at the beginning and at the end of the rehabilitation process for a multidisciplinary team at the patient’s home.

Results:

Prevalence of comorbidities of arterial hypertension and obesity. in the severe form of this disease. Mean difference in all P (Wilcoxon) scores <0.001 between baseline and post-rehabilitation status, presence of greater impairment in upper extremities.

Conclusions:

Patients with multiple sequelae that require early evaluation and intervention by a multidisciplinary team, home hospitalization being a safe, efficient and effective alternative. The restoration of safe and independent ambulation, the prevention of falls, safe eating, recovery of cognitive-communicative skills, and the empowerment of the family in a home context were achieved.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )